Literature DB >> 30012873

Risk Stratification of Type 2 Long-QT Syndrome Mutation Carriers With Normal QTc Interval: The Value of Sex, T-Wave Morphology, and Mutation Type.

Pyotr G Platonov1,2, Scott McNitt2, Bronislava Polonsky2, Spencer Z Rosero2, Valentina Kutyifa2, Allison Huang2, Arthur J Moss2, Wojciech Zareba2.   

Abstract

BACKGROUND: Long-QT (LQT) syndrome mutation carriers have higher risk of cardiac events than unaffected family members even in the absence of QTc prolongation. Changes in T-wave morphology may reflect penetrance of LQT syndrome mutations. We aimed to assess whether T-wave morphology may improve risk stratification of LQT2 mutation carriers with normal QTc interval.
METHODS: LQT2 mutation carriers with QTc <460 ms in men and <470 ms in women (n=154) were compared with unaffected family members (n=1007). Baseline ECGs recorded at age ≥18 years underwent blinded assessment. Flat, notched, or negative T waves in leads II or V5 were considered abnormal. Cox regression analysis was performed to assess the association between T-wave morphology, the presence of mutations in the pore region of KCNH2, and the risk of cardiac events defined as syncope, aborted cardiac arrest, defibrillator therapy, or sudden cardiac death. Sex-specific associations were estimated using interactions terms.
RESULTS: LQT2 female carriers with abnormal T-wave morphology had significantly higher risk of cardiac events compared with LQT2 female carriers with normal T waves (hazard ratio, 3.31; 95% confidence interval, 1.68-6.52; P=0.001), whereas this association was not significant in men. LQT2 men with pore location of mutations have significantly higher risk of cardiac events than those with nonpore mutations (hazard ratio, 6.01; 95% confidence interval, 1.50-24.08; P=0.011), whereas no such association was found in women.
CONCLUSIONS: The risk of cardiac events in LQT2 carriers with normal QTc is associated with abnormal T-wave morphology in women and pore location of mutation in men. The findings further indicate sex-specific differences in phenotype and genotype relationship in LQT2 patients.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  genotype; long-QT syndrome; mutation; risk; sex

Mesh:

Substances:

Year:  2018        PMID: 30012873      PMCID: PMC6090555          DOI: 10.1161/CIRCEP.117.005918

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  14 in total

1.  A quantitative assessment of T-wave morphology in LQT1, LQT2, and healthy individuals based on Holter recording technology.

Authors:  Martino Vaglio; Jean-Philippe Couderc; Scott McNitt; Xiaojuan Xia; Arthur J Moss; Wojciech Zareba
Journal:  Heart Rhythm       Date:  2007-08-28       Impact factor: 6.343

Review 2.  How do sex hormones modify arrhythmogenesis in long QT syndrome? Sex hormone effects on arrhythmogenic substrate and triggered activity.

Authors:  Katja E Odening; Gideon Koren
Journal:  Heart Rhythm       Date:  2014-06-19       Impact factor: 6.343

3.  Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome.

Authors:  Dimitry Migdalovich; Arthur J Moss; Coeli M Lopes; Jason Costa; Gregory Ouellet; Alon Barsheshet; Scott McNitt; Slava Polonsky; Jennifer L Robinson; Wojciech Zareba; Michael J Ackerman; Jesaia Benhorin; Elizabeth S Kaufman; Pyotr G Platonov; Wataru Shimizu; Jeffrey A Towbin; G Michael Vincent; Arthur A M Wilde; Ilan Goldenberg
Journal:  Heart Rhythm       Date:  2011-03-25       Impact factor: 6.343

4.  Vectorcardiography identifies patients with electrocardiographically concealed long QT syndrome.

Authors:  Daniel Cortez; J Martijn Bos; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2017-03-06       Impact factor: 6.343

5.  Electrocardiographic findings in patients with diphenhydramine overdose.

Authors:  W Zareba; A J Moss; S Z Rosero; R Hajj-Ali; J Konecki; M Andrews
Journal:  Am J Cardiol       Date:  1997-11-01       Impact factor: 2.778

6.  Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel.

Authors:  Arthur J Moss; Wojciech Zareba; Elizabeth S Kaufman; Eric Gartman; Derick R Peterson; Jesaia Benhorin; Jeffrey A Towbin; Mark T Keating; Silvia G Priori; Peter J Schwartz; G Michael Vincent; Jennifer L Robinson; Mark L Andrews; Changyong Feng; W Jackson Hall; Aharon Medina; Li Zhang; Zhiqing Wang
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

7.  Long QT syndrome in adults.

Authors:  Andrew J Sauer; Arthur J Moss; Scott McNitt; Derick R Peterson; Wojciech Zareba; Jennifer L Robinson; Ming Qi; Ilan Goldenberg; Jenny B Hobbs; Michael J Ackerman; Jesaia Benhorin; W Jackson Hall; Elizabeth S Kaufman; Emanuela H Locati; Carlo Napolitano; Silvia G Priori; Peter J Schwartz; Jeffrey A Towbin; G Michael Vincent; Li Zhang
Journal:  J Am Coll Cardiol       Date:  2007-01-04       Impact factor: 24.094

8.  2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).

Authors:  Silvia G Priori; Carina Blomström-Lundqvist; Andrea Mazzanti; Nico Blom; Martin Borggrefe; John Camm; Perry Mark Elliott; Donna Fitzsimons; Robert Hatala; Gerhard Hindricks; Paulus Kirchhof; Keld Kjeldsen; Karl-Heinz Kuck; Antonio Hernandez-Madrid; Nikolaos Nikolaou; Tone M Norekvål; Christian Spaulding; Dirk J Van Veldhuisen
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

9.  Genotype-phenotype aspects of type 2 long QT syndrome.

Authors:  Wataru Shimizu; Arthur J Moss; Arthur A M Wilde; Jeffrey A Towbin; Michael J Ackerman; Craig T January; David J Tester; Wojciech Zareba; Jennifer L Robinson; Ming Qi; G Michael Vincent; Elizabeth S Kaufman; Nynke Hofman; Takashi Noda; Shiro Kamakura; Yoshihiro Miyamoto; Samit Shah; Vinit Amin; Ilan Goldenberg; Mark L Andrews; Scott McNitt
Journal:  J Am Coll Cardiol       Date:  2009-11-24       Impact factor: 24.094

10.  ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome.

Authors:  A J Moss; W Zareba; J Benhorin; E H Locati; W J Hall; J L Robinson; P J Schwartz; J A Towbin; G M Vincent; M H Lehmann
Journal:  Circulation       Date:  1995-11-15       Impact factor: 29.690

View more
  7 in total

1.  Heart rate-corrected QT interval: A novel diagnostic biomarker for diabetic peripheral neuropathy.

Authors:  Ai-Jun Jiang; Heng Gu; Zhan-Rong Feng; Ying Ding; Xiao-Hua Xu; Guo-Ping Yin; Wen-Li Zhang; Zi-Yang Shen; Qian Li
Journal:  J Diabetes Investig       Date:  2022-01-06       Impact factor: 3.681

2.  Serine mutation of a conserved threonine in the hERG K+ channel S6-pore region leads to loss-of-function through trafficking impairment.

Authors:  Ehab Al-Moubarak; Yihong Zhang; Christopher E Dempsey; Henggui Zhang; Stephen C Harmer; Jules C Hancox
Journal:  Biochem Biophys Res Commun       Date:  2020-04-19       Impact factor: 3.575

Review 3.  Management of Congenital Long-QT Syndrome: Commentary From the Experts.

Authors:  Lee L Eckhardt; Elizabeth S Kaufman; Michael J Ackerman; Peter F Aziz; Elijah R Behr; Marina Cerrone; Mina K Chung; Michael J Cutler; Susan P Etheridge; Andrew D Krahn; Steven A Lubitz; Marco V Perez; Silvia G Priori; Jason D Roberts; Dan M Roden; Eric Schulze-Bahr; Peter J Schwartz; Wataru Shimizu; M Benjamin Shoemaker; Raymond W Sy; Jeffrey A Towbin; Sami Viskin; Arthur A M Wilde; Wojciech Zareba
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-07-09

4.  hiPSC-Derived Cardiomyocyte Model of LQT2 Syndrome Derived from Asymptomatic and Symptomatic Mutation Carriers Reproduces Clinical Differences in Aggregates but Not in Single Cells.

Authors:  Disheet Shah; Chandra Prajapati; Kirsi Penttinen; Reeja Maria Cherian; Jussi T Koivumäki; Anna Alexanova; Jari Hyttinen; Katriina Aalto-Setälä
Journal:  Cells       Date:  2020-05-07       Impact factor: 6.600

5.  An actionable KCNH2 Long QT Syndrome variant detected by sequence and haplotype analysis in a population research cohort.

Authors:  Shona M Kerr; Lucija Klaric; Mihail Halachev; Caroline Hayward; Thibaud S Boutin; Alison M Meynert; Colin A Semple; Annukka M Tuiskula; Heikki Swan; Javier Santoyo-Lopez; Veronique Vitart; Chris Haley; John Dean; Zosia Miedzybrodzka; Timothy J Aitman; James F Wilson
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

6.  Stem Cell-Based Disease Modeling and Cell Therapy.

Authors:  Xiaowen Bai
Journal:  Cells       Date:  2020-09-29       Impact factor: 6.600

Review 7.  Recent Non-Invasive Parameters to Identify Subjects at High Risk of Sudden Cardiac Death.

Authors:  Maria Delia Corbo; Enrica Vitale; Maurizio Pesolo; Grazia Casavecchia; Matteo Gravina; Pierluigi Pellegrino; Natale Daniele Brunetti; Massimo Iacoviello
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.